Phase 1 study on safety and PK of rovalpituzumab tesirine (Rova-T) in Japanese patients with advanced, recurrent SCLC

Kentaro Tanaka, Hibiki Udagawa, Hiroaki Akamatsu, Masayuki Takeda, Shintaro Kanda, Ikuko Yasuda, Sumiko Okubo, Shekman Wong, Charity Scripture, Tomohide Tamura, Isamu Okamoto

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)vii57
    JournalAnnals of oncology : official journal of the European Society for Medical Oncology
    Volume29
    DOIs
    Publication statusPublished - Oct 1 2018

    All Science Journal Classification (ASJC) codes

    • Hematology
    • Oncology

    Cite this